Bepra 20 Mg 14 Tablets

Bepra 20 Mg 14 Tablets

Description:

Bepra 20 mg 14 tablets is a prescription oral medicine containing rabeprazole sodium, a proton pump inhibitor (PPI) used to reduce excess stomach acid. It is commonly prescribed for the treatment of gastroesophageal reflux disease (GERD), heartburn, peptic ulcers, and other acid-related disorders. By selectively and irreversibly inhibiting the gastric proton pump (H+ / K+ ATPase) in the stomach’s parietal cells, Bepra 20 mg provides effective and long-lasting acid suppression, helping to relieve symptoms such as burning sensation in the chest, acid regurgitation, and upper abdominal pain, and supports healing of the esophagus and stomach lining.

Indications:

• Treatment of gastroesophageal reflux disease (GERD), including erosive or ulcerative reflux esophagitis.
• Relief of frequent heartburn and acid reflux symptoms such as burning in the chest, sour taste in the mouth, and acid regurgitation.
• Treatment and prevention of duodenal and gastric ulcers associated with excess gastric acid.
• Maintenance therapy to prevent relapse of GERD and peptic ulcers, as directed by a physician.
• Adjunctive therapy in conditions of pathological hypersecretion of gastric acid (e.g., Zollinger–Ellison syndrome), as prescribed by a specialist.

Active Ingredients / Key Components:

• Rabeprazole sodium – 20 mg per film-coated tablet.
• Other inactive ingredients/excipients: Not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Please refer to the package leaflet for the full list of excipients.

Dosage & Administration / How to Use:

• Usual adult dose for GERD and heartburn (as commonly prescribed): 20 mg (one tablet) once daily, or as directed by your physician.
• Tablets should be swallowed whole with a glass of water. Do not crush, chew, or split the film-coated tablets, as this may affect their efficacy.
• For optimal effect, take the tablet preferably before a meal (often before breakfast), unless your doctor advises otherwise.
• Duration of treatment varies according to the condition: short-term (usually 4–8 weeks) for ulcer healing or GERD, and longer-term for maintenance or hypersecretory conditions, strictly under medical supervision.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
• Use in children and adolescents: Only if specifically prescribed by a pediatric specialist, as dosing and safety depend on age and weight.

Clinical Benefits:

• Provides potent and sustained suppression of gastric acid secretion by irreversibly inhibiting the proton pump (H+ / K+ ATPase) in gastric parietal cells.
• Helps relieve symptoms of heartburn, acid reflux, and epigastric pain, improving daily comfort and quality of life.
• Promotes healing of erosive esophagitis, gastric ulcers, and duodenal ulcers by reducing acid-mediated damage to the mucosa.
• Supports mucin synthesis and protection of the gastric lining, aiding in mucosal defense and ulcer prevention.
• Offers relatively rapid onset of acid suppression among proton pump inhibitors, providing quicker symptom relief in many patients.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity or allergy to rabeprazole, substituted benzimidazoles, or any component of the formulation.
• Do not use without medical supervision if you experience alarm symptoms such as unintentional weight loss, persistent vomiting, difficulty swallowing, vomiting blood, or black/tarry stools; these may indicate serious gastrointestinal disease requiring further investigation.
• Long-term use of proton pump inhibitors may be associated with increased risk of bone fractures (hip, wrist, spine), vitamin B12 deficiency, hypomagnesemia, and gastrointestinal infections (e.g., Clostridioides difficile). Periodic monitoring may be required for long-term therapy.
• Use with caution in patients with severe liver impairment; dose adjustment or close monitoring may be necessary. Inform your doctor of any history of liver disease.
• Rabeprazole may interact with certain medications (e.g., some antifungals, HIV medications, methotrexate, warfarin, digoxin, and drugs whose absorption depends on gastric pH). Always inform your doctor and pharmacist about all medicines and supplements you are taking.
• Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy should only occur if clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding. It is not clearly known whether rabeprazole passes into breast milk; your doctor will weigh potential benefits and risks.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.
• Do not exceed the prescribed dose or duration of treatment. Abrupt discontinuation after long-term use may cause rebound acid hypersecretion; follow your doctor’s instructions for tapering if needed.

Side Effects:

• Common side effects may include headache, dizziness, abdominal pain, diarrhea, constipation, flatulence, nausea, or vomiting.
• Less common side effects can include dry mouth, rash, itching, or sleep disturbances.
• Serious but rare side effects may include severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing), severe skin reactions, jaundice (yellowing of skin or eyes), or signs of low magnesium (muscle cramps, irregular heartbeat, seizures). Seek immediate medical attention if these occur.
• Inform your doctor if you experience persistent or bothersome side effects, or any unusual symptoms while taking Bepra 20 mg.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the outer carton to protect from light. Do not store above the temperature specified on the package (typically below 25–30 °c; check local pack instructions). Keep container tightly closed and keep out of reach of children. Do not use after the expiry date printed on the pack.

Specifications:

• Product type: Prescription medicine – proton pump inhibitor (PPI).
• Strength: 20 mg rabeprazole sodium per film-coated tablet.
• Form: Film-coated tablets for oral use.
• Pack size: 14 tablets per pack.
• Intended users: Adults and adolescents as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.